Single cell transcriptomics symposium 2018

DPBM-151, 1cr

Thursday the 20th September 2018

Biomedicum Helsinki, Haartmaninkatu 8, Lecture Hall 1

Registration open until 13th September 2018 at:

https://elomake.helsinki.fi/lomakkeet/91489

Preliminary program

9:00-9:05 Welcoming words

9:05-9:25 Anna Vähärautio (University of Helsinki): High-grade serous ovarian cancer cellular states related to clinical response

9:25-9:50 Eevi Kaasinen (University of Helsinki): Molecular and clinical characterisation of constitutional TET2 haploinsufficiency

Coffee break with sponsor exhibition

10:20-10:40 Pirkko Mattila (University of Helsinki): Single cell gene expression profiling of samples from AML patients in different disease states

10:40-11:20 Merja Heinäniemi (University of Eastern Finland): Aberrant regulatory landscape in acute lymphoblastic leukemia with ETV6-RUNX1 fusion

Lunch break, lunch seminar with sponsor presentations at Faculty Club, 6th floor with free lunch for the first 40 registrants

13:00-13:20 Päivi Saavalainen (University of Helsinki): Drug response biomarkers in inflammatory bowel disease

13:20-14:00 Stefania Giacomello (Spatial Transcriptomics AB & KTH Royal Institute of Technology, Stockholm): Combining Spatial Transcriptomics and single-cell RNA-sequencing to study the development of the human fetal heart

14:00-14:40 Bart Deplancke (EPFL, Lausanne): Single-cell RNA-seq-based characterisation of somatic (adipose) stem cells & precursors

Coffee break with sponsor exhibition

15:10-15:50 Sagar (Max Planck Institute of Immunobiology and Epigenetics, Freiburg): Deciphering the Regulatory Landscape of γδ T-cell Development by single-cell RNA-sequencing

15:50-16:30 Stein Aerts (VIB-KU, Leuven): Single-cell Gene Regulatory Networks

16:30-16:40 Closing the symposium

19:00 Speakers' dinner

Organizers: Päivi Saavalainen, Anna Vähärautio, Pirkko Mattila and Outi Monni

Sponsors: Doctoral Program in Biomedicine (DPBM), Illumina, 10x Genomics, Dolomite-Bio, Celsee, ProteinSimple, Immunodiagnostics, Cellenion, AH Diagnostics, Fluidigm